There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Combined modality therapy in the treatment of retinoblastoma may decrease treatment-related
morbidity and second tumor-associated mortality, while maintaining excellent tumor
control rates.